GERON CORP Increase (Decrease) in Other Current Assets
GERON CORP (GERN) reported Increase (Decrease) in Other Current Assets of $401.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2017-11-01
- GERON CORP increase (decrease) in other current assets for the quarter ending 2017-09-30 was -$5.55M, a 202.53% decline year-over-year.
- GERON CORP increase (decrease) in other current assets for the quarter ending 2017-06-30 was -$49.00K.
- GERON CORP increase (decrease) in other current assets for the quarter ending 2017-03-31 was $6.00M.
- GERON CORP increase (decrease) in other current assets for the quarter ending 2016-09-30 was $5.42M, a 3534.90% increase year-over-year.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month |
|---|---|---|---|
| 2017-09-30 | -$5.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$5.60M derived: sum of 2 quarters · filed 2017-11-01 | $401.00K 10-Q · filed 2017-11-01 |
| 2017-06-30 | -$49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $5.95M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $6.00M 10-Q · filed 2017-05-09 | ||
| 2016-09-30 | $5.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $5.21M derived: sum of 2 quarters · filed 2017-11-01 | $4.40M 10-Q · filed 2017-11-01 |
| 2016-06-30 | -$206.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$1.02M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | -$813.00K 10-Q · filed 2017-05-09 | ||
| 2015-09-30 | $149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $275.00K derived: sum of 2 quarters · filed 2016-11-03 | $370.00K 10-Q · filed 2016-11-03 |
| 2015-06-30 | $126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $221.00K 10-Q · filed 2016-08-03 | |
| 2015-03-31 | $95.00K 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |